Similar Diseases
- ARSACS
- ARSAL
- Autosomal dominant spastic ataxia type 7
- Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome
- AD-SPAX
- AR-SPAX
- Autosomal recessive spastic ataxia type 2
- Autosomal dominant spastic ataxia type 1
- Autosomal recessive spastic paraplegia 35
- AFG3L2-related spastic ataxia-myoclonic epilepsy-neuropathy syndrome
Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin
Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)
Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies
Results for Query ‹ ARSACS risk ›
Autosomal recessive spastic ataxia of Charlevoix-Saguenay – Genetics
The inheritance pattern is autosomal recessive. The disorder is caused by a mutation in the SGCG on chromosome 13. The mutation of the SACS gene causes the production of an unstable, poorly functioning SACSIN protein. It is unclear as to how this mutation affects the central nervous system (CNS) and skeletal muscles presenting in the signs and symptoms of ARSACS.
Autosomal recessive spastic ataxia of Charlevoix-Saguenay – Prognosis
Most patients begin to use a wheelchair for movement around age 30-40. Death usually occurs in their 60s, but some have been reported to live longer.